These results indicate that HNRNPLL stabilizes mRNA encoding regulators of DNA replication and promotes colorectal cancer cell proliferation.
at mRNA level during epithelial-mesenchymal transition (EMT) and is restored during mesenchymal-epithelial transition (MET) in colorectal cancer cells. 4 Downregulation of HNRNPLL during EMT or that by knockdown of HNRNPLL by shRNA modulates the alternative splicing of CD44 to increase CD44 variable exon 6 (CD44v6), which enhances the invasion activity of colorectal cancer cells. 4 Definition of metastasis suppressors requires that they do not inhibit tumor cell proliferation, because growth suppression could lead to apparent suppression of invasion/metastasis. HNRNPLL knockdown did not enhance colorectal cancer cell proliferation but suppressed their proliferation instead, suggesting the proliferationpromoting effect of HNRNPLL. 4 While our previous finding clearly demonstrated that HNRNPLL suppressed invasion/metastasis through regulation of pre-mRNA splicing of CD44, the alternative splicing of CD44 may not explain the possible proliferation-promoting effect of HNRNPLL.
hnRNP family proteins are involved in various steps of RNA metabolism, including transcription, nuclear export, mRNA stability, and mRNA translation, in addition to pre-mRNA splicing. 5 Dysregulation of HNRNP proteins is known to help cancer progression through their nonsplicing functions. 6 For example, HNRNPK has been shown to promote proliferation of colorectal cancer cells by regulating not only pre-mRNA splicing of MRPL33, 7 but also transcription of CDKN2B 8 and MMP2, 9 mRNA stability of CDK6, 10 and mRNA translation of BTK.
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In this study, we address the role of HNRNPLL in proliferation of
colorectal cancer cells and demonstrate that HNRNPLL stabilizes mRNA encoding regulators of DNA replication and enhances cell cycle progression.
| MATERIALS AND METHODS

| Cell culture
Human colon cancer cell lines SW480 and HT29 were obtained from ATCC (Manassas, VA, USA) and were maintained in DMEM (Nacalai Tesque, Kyoto, Japan) supplemented with 10% FBS (Thermo Fisher Scientific, Waltham, MA, USA). Actinomycin D (Sigma-Aldrich, St.
Louis, MO) was added into the culture medium at a final concentration of 1 μg/mL. The cell number was determined using a TC20 cell counter (Bio-Rad, Hercules, CA, USA).
| Lentiviral transduction
pLKO.1 lentiviral shRNA vectors for Luciferase (TRCN0000072259) and HNRNPLL (sh1, TRCN0000075098; sh2, TRCN0000075101)
were obtained from Sigma-Aldrich. Lentiviral cDNA expression vectors were constructed by subcloning the coding region sequence into pLEX-MCS (GE Healthcare, Buckinghamshire, UK). Lentivirus was produced by transfecting these vectors into HEK293T cells with packaging plasmids using Lipofectamine 2000 (Thermo Fisher Scientific). The culture supernatants were used for infecting cells with 8 μg/mL of polybrene (Sigma-Aldrich). 
| Western blot
| RNA sequencing
Total RNA was extracted with ISOGEN (Nippon Gene, Tokyo, Japan).
A sequencing library was prepared using the TruSeq stranded mRNA sample prep kit (Illumina, San Diego, CA 
| Cell cycle analysis
Cells were harvested and fixed in 70% ethanol overnight at −30°C.
After centrifugation, the pellets were suspended in PBS(−) containing 50 μg/mL of propidium iodide (Dojindo, Kumamoto, Japan) and 50 μg/mL of RNase A (Nippon Gene) at 37°C for 60 min and were analyzed with a FACSCalibur (BD Biosciences, Franklin Lakes, NJ, USA).
| Quantitative RT-PCR
First-strand cDNA was prepared with a High-Capacity cDNA Reverse
Transcription Kit using oligo(dT) primers (Thermo Fisher Scientific).
The cDNA templates were mixed with FAM-labeled TaqMan Gene Expression Assays and TaqMan Gene Expression Master Mix (Thermo Fisher Scientific), followed by amplification using a 7500
Fast Real-Time PCR System (Thermo Fisher Scientific) according to the manufacturer's protocol. Assay IDs of the TaqMan Gene Expression Assays used in this study are listed in Supplementary Table S2 .
The results were obtained as relative transcript levels to GAPDH using the comparative CT method. 
| siRNA transfection
Relative expression levels 
| Immunostaining
For immunocytological staining, cells were fixed with 4% formaldehyde followed by permeabilization with methanol at −30°C for 10 min. Human colorectal cancer sections were prepared from surgical tissues collected at Aichi Cancer Center Hospital under informed consent. The paraffin sections were subjected to deparaffinization and antigen retrieval in heated citrate buffer for 30 min. The cells and sections were blocked with PBS(−) containing 5% normal goat serum and 0.3% Triton X-100 for 60 min, incubated with primary antibodies overnight at 4°C, and then with Alexa-conjugated secondary antibodies for 2 h at room temperature. TO-PRO-3 Iodide (Thermo Fisher Scientific) was used for nuclear staining. The stained sections were observed and photographed with an LSM800 confocal microscope (Carl Zeiss, Jena, Germany).
| Statistical analyses
The statistical significance was assessed by unpaired Student's t test using the Microsoft Excel software (Microsoft, Redmond, WA). This function of CDT1 is inhibited by GMNN (also known as Geminin) through a direct interaction, 13 followed by destabilization of CDT1 after initiation of S phase, 12 while GMNN, which accumulates during S, G2 and M phases, is degraded at the metaphase-anaphase transition. 14 CDT1 and GMNN are, thus, considered useful markers of G1 and S/G2/M phases, respectively. 15 The Figure S1C) , which is consistent with our previous finding. 4 Several genes were noted for altered exon usage, which suggests that the alternative splicing of these genes may be modulated by HNRNPLL, and the genes are currently under investigation in detail. Intriguingly, we also found a large number of genes showing altered gene expression levels.
Namely, 1514 genes were upregulated in the HNRNPLL overexpressing cells by more than threefold as compared to the HNRNPLL knocked down cells, while 2190 genes were upregulated in the HNRNPLL knocked down cells by more than threefold as compared to the HNRNPLL overexpressing cells. We performed gene We found that PCNA, RFC3 and FEN1 were highly expressed in 31.6%, 47.4% and 5.3%, respectively, of the patients with a high level of HNRNPLL (n = 19), whereas they were highly expressed in 11.4%, 20.8% and 1.9%, respectively, of the patients with low or middle levels of HNRNPLL expression (n = 360) ( Table 2) | 2465 encircling DNA to enhance the processivity of DNA polymerases δ and ε, which are required for the synthesis of the lagging and leading strands, respectively. 19 PCNA is, thus, categorized as a DNA clamp.
RFC3 is 1 of the 5 subunits of replication factor C (RFC), which is classified as a clamp loader because it loads PCNA around DNA.
20
FEN1 is an endonuclease known for its essential roles in the maturation of Okazaki fragment and long-patch base excision repair. 21 As expected from the pivotal functions of PCNA, RFC3and FEN1 in DNA replication, dysregulated expression of these proteins has been linked to cancer. Specifically, PCNA is a well-established proliferation marker in some types of cancer. [22] [23] [24] RFC3 is associated with proliferation activity of breast cancer cells 25 or poor prognosis in ovarian cancer patients. 26 Overexpression of FEN1 has been associated with enhanced cancer cell proliferation or poor clinical outcome in gastric, 27 breast, 28 ovarian 28 and non-small-cell lung cancer. 29 FEN1 is known to be activated by PCNA 30 and RFC, 31 indicating
HNRNPLL CDKN1A
TO-PRO-3 KRT20 This strategy may be difficult because knockdown of HNRNPLL in colorectal cancer cells significantly enhanced invasion activity in vitro and increased lung metastasis in vivo. 4 Nevertheless, inhibition of excessive HNRNPLL expression can be a potential strategy for tumor volume reduction. To identify the molecules regulating HNRNPLL overexpression, it will be important to elucidate the mechanism of the transcriptional regulation of HNRNPLL, which is currently under investigation.
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